Cargando…
Current understanding on molecular drug targets and emerging treatment strategy for novel coronavirus-19
SARS-CoV-2 is an enveloped positive-sense RNA virus, contain crown-like spikes on its surface, exceptional of large RNA genome, and a special replication machinery. Common symptoms of SARS-CoV-2 include cough, common cold, fever, sore throat, and a variety of severe acute respiratory disease (SARD)...
Autores principales: | Raj, Khadga, Kaur, Karamjeet, Gupta, G. D., Singh, Shamsher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102151/ https://www.ncbi.nlm.nih.gov/pubmed/33961065 http://dx.doi.org/10.1007/s00210-021-02091-5 |
Ejemplares similares
-
Coronavirus as silent killer: recent advancement to pathogenesis, therapeutic strategy and future perspectives
por: Raj, Khadga, et al.
Publicado: (2020) -
Understanding the Role of Histone Deacetylase and their Inhibitors in Neurodegenerative Disorders: Current Targets and Future Perspective
por: Kumar, Vishal, et al.
Publicado: (2022) -
Possible Targets of Pan-Coronavirus Antiviral Strategies for Emerging or Re-Emerging Coronaviruses
por: Li, Xue, et al.
Publicado: (2021) -
Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation
por: Cho, Hanhee, et al.
Publicado: (2022) -
Biomarkers in renal cell carcinoma and their targeted therapies: a review
por: Gupta, Shruti, et al.
Publicado: (2023)